Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
- Conditions
- Delayed Graft FunctionKidney FunctionKidney Transplant; Complications
- Interventions
- Registration Number
- NCT03071536
- Lead Sponsor
- King Chulalongkorn Memorial Hospital
- Brief Summary
Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 180
- Deceased donor kidney transplantation at KCMH
- informed consent is accepted
- Known allergy to furosemide
- Surgical complication of allograft
- Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Furosemide Furosemide Injection Single dose of furosemide 1.5 mg/kg intravenously will be given to all participants at 3 hours post-reperfusion of kidney allograft. Urine output will be recorded hourly for 6 hours.
- Primary Outcome Measures
Name Time Method Urine output 6 hours Urine output per hour (milliliters/hour) after furosemide injection
- Secondary Outcome Measures
Name Time Method Delayed graft function 7 days Delayed graft function is defined by the necessity of dialysis within the first week after kidney transplantation. (yes/no)
Creatinine reduction ratio At postoperative day 0,7 and 14 Ratio of serum creatinine at postoperative day 7 and 14 to day-zero creatinine
Trial Locations
- Locations (1)
King Chulalongkorn Memorial Hospital
🇹ðŸ‡Bangkok, Thailand